<p>Monocyte-derived macrophages were incubated for 16 h in the presence of 50 µg/ml of DiI-oxLDL and/or with LAD2 (A) or primary mast cell (B) releasate, and/or with specific blocking antibodies for CD36 and MSR1 (2 µg/ml), or with isotype control antibodies IgG1 and IgA (2 µg/ml), or with 20-fold excess of unlabeled oxLDL to determine the magnitude of the high-affinity uptake of Dil-oxLDL. DiI fluorescence was measured from cell lysates. The results are presented as means ± SEM (n = 4 donors). *p<0.05, **p<0.01, ***p<0.001.</p
<p>Adherent monocytes/macrophages were treated with LY294002 (10 µM, 30 min) and then stimulated wit...
<p>Relative quantitative RT-PCR (qRT-PCR) for CD36 in macrophages (<b>A</b>) and foam cells (<b>B</b...
In J774 murine macrophages, chemically oxidized LDL (OxLDL) and biologically oxidized LDL (BioOxLDL)...
<p>Monocyte-derived macrophages were incubated with 50 µg/ml of DiI-oxLDL and/or in LAD2 (A, C, E) o...
Primary human macrophages were treated with PBS control, native LDL or oxLDL (1, 10 or 25 μg/ml) ove...
<p>Macrophages were treated with oxLDL (30 μg/mL) or PAF (10<sup>-7</sup> mol/L) for 20 min at 37°C ...
<p>Macrophages were treated with mAb to CD36 (1:500) alone or in combination with WEB2170 (50 µmol/L...
Primary human macrophages were treated with PBS control, native LDL or oxLDL (1, 10 or 25 μg/ml) ove...
<p>(A)–(C) SMCs were incubated for increasing amount of time (30, 60,120 and 240 min with 50 ug/mL)o...
<p>Macrophages were treated with βCD (2 mmol/L) or with the inactive analog αCD for 5 min. The uptak...
<p>Adherent human monocytes/macrophages were treated with WEB2170 (50 µM) or CV3988 (10 µM) for 30 m...
Oxidized low-density lipoproteins (oxLDL) and oxLDL-containing immune complexes (oxLDL-IC) contribut...
AbstractMitogen activated protein kinase in extracts of U-937 macrophage-like cells was stimulated b...
Oxidized low-density lipoproteins (oxLDL) and oxLDL-containing immune complexes (oxLDL-IC) contribut...
Oxidized low-density lipoprotein (oxLDL) is considered one of the principal effectors of atherogenes...
<p>Adherent monocytes/macrophages were treated with LY294002 (10 µM, 30 min) and then stimulated wit...
<p>Relative quantitative RT-PCR (qRT-PCR) for CD36 in macrophages (<b>A</b>) and foam cells (<b>B</b...
In J774 murine macrophages, chemically oxidized LDL (OxLDL) and biologically oxidized LDL (BioOxLDL)...
<p>Monocyte-derived macrophages were incubated with 50 µg/ml of DiI-oxLDL and/or in LAD2 (A, C, E) o...
Primary human macrophages were treated with PBS control, native LDL or oxLDL (1, 10 or 25 μg/ml) ove...
<p>Macrophages were treated with oxLDL (30 μg/mL) or PAF (10<sup>-7</sup> mol/L) for 20 min at 37°C ...
<p>Macrophages were treated with mAb to CD36 (1:500) alone or in combination with WEB2170 (50 µmol/L...
Primary human macrophages were treated with PBS control, native LDL or oxLDL (1, 10 or 25 μg/ml) ove...
<p>(A)–(C) SMCs were incubated for increasing amount of time (30, 60,120 and 240 min with 50 ug/mL)o...
<p>Macrophages were treated with βCD (2 mmol/L) or with the inactive analog αCD for 5 min. The uptak...
<p>Adherent human monocytes/macrophages were treated with WEB2170 (50 µM) or CV3988 (10 µM) for 30 m...
Oxidized low-density lipoproteins (oxLDL) and oxLDL-containing immune complexes (oxLDL-IC) contribut...
AbstractMitogen activated protein kinase in extracts of U-937 macrophage-like cells was stimulated b...
Oxidized low-density lipoproteins (oxLDL) and oxLDL-containing immune complexes (oxLDL-IC) contribut...
Oxidized low-density lipoprotein (oxLDL) is considered one of the principal effectors of atherogenes...
<p>Adherent monocytes/macrophages were treated with LY294002 (10 µM, 30 min) and then stimulated wit...
<p>Relative quantitative RT-PCR (qRT-PCR) for CD36 in macrophages (<b>A</b>) and foam cells (<b>B</b...
In J774 murine macrophages, chemically oxidized LDL (OxLDL) and biologically oxidized LDL (BioOxLDL)...